Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...

Sr. Spec. DDIT IES Cloud Engineering Regular, Full time Universal Hierarchy Node India +Alternative Locations Hyderabad (Office) Giu 05, 2025 Assoc. Dir. DDIT IES Cloud Engineering Regular, Full time ...

Sort by Sort ascending 職種Sort ascending 部門国勤務地掲載日 職種Sort ascending 部門国勤務地掲載日 Supply Chain Planning and Logistics Senior SpecialistRegular, Full time Innovative Medicines Spain Zaragoza Jun 05, 2025 ...

The mental health and wellbeing of our people is vitally important. It is a natural extension of our company’s purpose to ...

Sr. Spec. DDIT IES Cloud Engineering Regular, Full time Universal Hierarchy Node Indien +Alternative Locations Hyderabad (Office) Jun 05, 2025 Assoc. Dir. DDIT IES Cloud Engineering Regular, Full time ...

Sr. Spec. DDIT IES Cloud Engineering Regular, Full time Universal Hierarchy Node India +Alternative Locations Hyderabad (Office) junho 05, 2025 Assoc. Dir. DDIT IES Cloud Engineering Regular, Full ...

Sr. Spec. DDIT IES Cloud Engineering Regular, Full time Universal Hierarchy Node Indien +Alternative Locations Hyderabad (Office) Juni 05, 2025 ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.

Wij nodigen u uit om ons alle mogelijke bijwerkingen gerelateerd aan één van onze geneesmiddelen te melden. Zo kunnen wij onze kennis over mogelijke bijwerkingen verbeteren en zo tijdig de patiënten ...

Novartis is investigating a broad portfolio of RLTs in advanced cancers, including breast, colon, lung and pancreatic and is investing in multiple manufacturing facilities, with industry-leading ...